Abstract:AbstractBackgroundStudies using standardized cognitive assessments across disparate populations are often confounded by sociocultural differences, leading to a lack of comparative standards to assess the degree of Mild cognitive impairment (MCI). Thus, testing in diverse populations is essential in validating biomarkers for MCI and avoiding race and cultural confounders. Applying an identical, cross‐culturally accepted, non‐invasive, electrophysiological protocol, we test the hypothesis that the frontal neuromarkers for MCI are consistent in two samples of older adults in the US and China.MethodUsing an identical, clinically friendly protocol with a wireless 14‐channel headset (eMotiv), we recorded EEG signals along with accuracy and reaction times during a visual object working memory task in two samples of older adults. The Kentucky sample includes 12 Normal Cognition NC; (Mean age 68); 7 MCI (age 81) while the Beijing sample includes 11 NC (age 64) and 16 MCI (age 65). Each participant also received assessments in NACC UDS 3.0. The 10‐min task asked each subject to remember two visual objects and then determine whether the subsequent object is a Match or Nonmatch to one of the two held in working memory.ResultWe found that left frontal sites showed significant mean amplitude differences between MCI and NC during target match retrievals. The persons with MCI showed reduced responses to memory targets at the F3 and F7 sites in Kentucky. The MCIs’ reduction patterns were significant in the left frontal F3 but not significant at F7 in Beijing sample. The Beijing participants were on average younger than KY participants, leading to a reduction in quantitative signal change, however, the effect remains robust and parallels those from Kentucky. The current results using a fast and two‐target memory task are consistent with previously reported results using 64‐channels and a longer version of the memory task with single‐target.ConclusionWe have validated frontal neuromarkers for MCI risk in two diverse samples. The current finding has significant implications for clinical practice which creates a path for the next step: large‐scale, low‐cost, and culturally‐accepted screening for risk of cognitive decline in individuals, irrespective of their socio‐cultural, geographical, or societal background.

Selection of a Neuropsychological Battery for Vascular Cognitive Impairment-No Dementia in China

Validation of NINDS-CSN neuropsychological battery for vascular cognitive impairment in Chinese stroke patients

The characteristic of neuropsychology in patients with vascular cognitive impairment-no dementia with small vessel disease

Visual Cognitive Assessment Test: Utility of the brief cognitive battery for early screening of cognitive impairment in Chongqing, China

Clinical application of Chinese version of neuropsychological test battery in the dignosis of mild cognitive impairment in the elderly objectives

A Neuropsychological Battery for the Evaluation of Dementia Among Mandarin-Speaking Older Adults in the United States

A clinical memory battery for screening for amnestic mild cognitive impairment in an elderly chinese population.

What is the Optimal Neuropsychological Test Battery for Schizophrenia in China?

A1362 Bayesian Estimation on Diagnostic Performance of Dementia Screening Tests in the Absence of a Gold Standard

Comparison Of Vascular Cognitive Impairment - No Dementia By Multiple Classification Methods

Estimation of diagnostic performance of dementia screening tests: Mini-Mental State Examination, Mini-Cog, Clock Drawing test and Ascertain Dementia 8 questionnaire.

Validation of Neuropsychological Tests to Screen for Dementia in Chinese Patients with Parkinson's Disease.

Shanghai Community Brain Health Initiative Pilot Study: Neuropsychological Results

Abstract TP440: The Discriminant Validity of the NINDS-CSN Harmonization Neurocognitive Battery in Detecting VCI in Singaporean Patients with Ischemic Stroke and TIA

Diagnostic Accuracy of the Chinese Version of the Trail‐Making Test for Screening Cognitive Impairment

Normative Data on a Battery of Neuropsychological Tests in the Han Chinese Population

Cross-cultural difference and validation of the Chinese version of Montreal Cognitive Assessment in older adults residing in Eastern China: preliminary findings.

Neuropsychological Examination in Patients with Mild Cognitive Impairment

A Comparison Study of Mild Cognitive Impairment with 3 Memory Tests among Chinese Individuals.

A novel language-neutral Visual Cognitive Assessment Test (VCAT): validation in four Southeast Asian countries

Validating Frontal Memory‐related Neuromarkers for Mild Cognitive Impairment Using Identical Protocols in Two Racial and Culturally Distinct Cohorts